Evidence map›Paper›PMID 23299987›Full record

Trial reportHuman genetics2013

Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility.

Mateusz Siedlinski, Dustin Tingley, Peter J Lipman, Michael H Cho, Augusto A Litonjua, David Sparrow, Per Bakke, Amund Gulsvik, David A Lomas, Wayne Anderson and 8 more

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Human genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Clarifying Chronic Obstructive Pulmonary Disease Genetic Associations Observed in Biobanks via Mediation Analysis of Smoking.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genetics of COPD.Annual review of physiology · 2020
    Review
  18. Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.American journal of respiratory and critical care medicine · 2019
    Review
  19. Review
  20. Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Mateusz SiedlinskiChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. remts@channing.harvard.edu
Dustin Tingley
Peter J Lipman
Michael H Cho
Augusto A Litonjua
David Sparrow
Per Bakke
Amund Gulsvik
David A Lomas
Wayne Anderson
Xiangyang Kong
Stephen I Rennard
Terri H Beaty
John E Hokanson
James D Crapo
Christoph Lange
Edwin K Silverman
COPDGene and ECLIPSE Investigators
Brigham and Women's Hospital · USBoston University · USHarvard University · USJohns Hopkins University · USResearch Triangle Park Foundation · USColorado School of Public Health · USGlaxoSmithKline (United States) · USHaukeland University Hospital · NOUniversity of Cambridge · GB

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Systems Biology, Bioinformatics, and BiostatisticsP01HL105339 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2011 to 2015
$12.2M
Statistical GeneticsP01HL083069 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2011
$12.2M
Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Genetic Determinants of COPD in Diverse Ethnic GroupsR01HL084323 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2010
$2.6M
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDYR01HL094635 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HERSH, CRAIG P · 2009 to 2014
$2.2M
Translational Genetics and Genomics of Airways DiseasesK12HL089990 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2012
$1.9M
Community Assist of Southern ArizonaR25ES011080 · NIEHS · CHILD AND FAMILY RESOURCES, INC. · PI ESTRADA, RAMON M · 2001 to 2004
$771k
APPROACHES TO IDENTIFY RARE AND COMMON GENETIC DETERMINANTS IN SEVERE COPDK08HL097029 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H. · 2010 to 2013
$548k
Medical Research Council G0901697Medical Research Council G0901786NHLBI NIH HHS K08 HL097029NHLBI NIH HHS K12 HL089990NHLBI NIH HHS K12HL089990NHLBI NIH HHS P01 HL083069NHLBI NIH HHS P01 HL105339NHLBI NIH HHS R01 HL075478NHLBI NIH HHS R01 HL084323NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R01 HL094635NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NIEHS NIH HHS R25 ES011080
6 · The paper itself

Abstract

Cigarette smoking is the major environmental risk factor for chronic obstructive pulmonary disease (COPD). Genome-wide association studies have provided compelling associations for three loci with COPD. In this study, we aimed to estimate direct, i.e., independent from smoking, and indirect effects of those loci on COPD development using mediation analysis. We included a total of 3,424 COPD cases and 1,872 unaffected controls with data on two smoking-related phenotypes: lifetime average smoking intensity and cumulative exposure to tobacco smoke (pack years). Our analysis revealed that effects of two linked variants (rs1051730 and rs8034191) in the AGPHD1/CHRNA3 cluster on COPD development are significantly, yet not entirely, mediated by the smoking-related phenotypes. Approximately 30% of the total effect of variants in the AGPHD1/CHRNA3 cluster on COPD development was mediated by pack years. Simultaneous analysis of modestly (r (2) = 0.21) linked markers in CHRNA3 and IREB2 revealed that an even larger (~42%) proportion of the total effect of the CHRNA3 locus on COPD was mediated by pack years after adjustment for an IREB2 single nucleotide polymorphism. This study confirms the existence of direct effects of the AGPHD1/CHRNA3, IREB2, FAM13A and HHIP loci on COPD development. While the association of the AGPHD1/CHRNA3 locus with COPD is significantly mediated by smoking-related phenotypes, IREB2 appears to affect COPD independently of smoking.

Indexed as

Genetic LociGenetic Predisposition to DiseaseMultigene FamilyPolymorphism, Single NucleotideAgedCarrier ProteinsCase-Control StudiesFemaleGenome-Wide Association StudyGTPase-Activating ProteinsHumansIron Regulatory Protein 2MaleMembrane GlycoproteinsMiddle AgedPulmonary Disease, Chronic ObstructiveCarrier ProteinsFAM13A protein, humanGTPase-Activating ProteinsHHIP protein, humanIron Regulatory Protein 2Membrane GlycoproteinsReceptors, Nicotinic

Identifiers

PMID23299987
PMCPMC3600068
OpenAlexW2097482510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.